Cheng Li

Stock Analyst at Oppenheimer

(n/a)
# 4,637
Out of 5,072 analysts
2
Total ratings
n/a
Success rate
-33.31%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Cheng Li

Wave Life Sciences
Jul 28, 2025
Initiates: Outperform
Price Target: $24
Current: $7.67
Upside: +212.91%
Vaxart
Aug 15, 2024
Initiates: Outperform
Price Target: $4
Current: $0.36
Upside: +1,011.11%